Forward Citations = 131

Loading Chart...

2 inventors (with patents filed for the assignee):

James M Dunn (7 out of 15 patents)

Ronald T Haas (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 4525345 - Constant order release, solid dosage indomethacin formulation and method (1985-06-25),

2. 4522804 - Constant release rate solid oral dosage formulations of propranolol (1985-06-11),

3. 4521402 - Constant release rate solid oral dosage formulations of hydrazine (1985-06-04),

4. 4521401 - Constant release rate solid oral dosage formulations of quinidine (1985-06-04),

5. 4520009 - Sustained released aspirin formulation (1985-05-28),

6. 4461759 - Constant release rate solid oral dosage formulations of veropamil (1984-07-24),

7. 4375468 - Constant order release aspirin composition and method of treating (1983-03-01),

Company Overview

Verex Laboratories, Inc. is a leading pharmaceutical company specializing in the development, manufacturing, and distribution of high-quality generic and branded prescription medications. With a focus on innovation and customer satisfaction, Verex Laboratories is committed to providing healthcare solutions that improve the quality of life for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#74 in Englewood, CO

#870 in Colorado

#39,929 in US

Englewood, CO, United States of America

Verex Laboratories, Inc.

Forward Citations = 131

2 inventors:

James M Dunn (7 out of 15 patents)

Ronald T Haas (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Verex Laboratories, Inc.. Retrieved from https://idiyas.com/company/verex-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]